ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1L14338
Home | Market Reports | Health| Health Conditions| Cancer
Global Chemotheraphy induced Nausea and Vomitting Treatment Market Research Report 2023
BUY CHAPTERS

Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Research Report 2025

Code: QYRE-Auto-1L14338
Report
July 2025
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Helsinn
Heron Therapeutics
Merck
Tesaro
Acacia Pharma
Aphios
Barr Laboratories
Baxter Healthcare
Eisai Co Ltd
Especificos Stendhal
F.Hoffmann-La Roche
Mundipharma
Mylan Pharmaceuticals
OPKO Health
Orchid Healthcare

Chemotheraphy-induced Nausea and Vomitting Treatment Market Size

The global market for Chemotheraphy-induced Nausea and Vomitting Treatment was valued at US$ 2284 million in the year 2024 and is projected to reach a revised size of US$ 1993 million by 2031, growing at a CAGR of -2.0% during the forecast period.

Chemotheraphy-induced Nausea and Vomitting Treatment Market

Chemotheraphy-induced Nausea and Vomitting Treatment Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Chemotheraphy-induced Nausea and Vomitting Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chemotheraphy-induced Nausea and Vomitting Treatment.
The Chemotheraphy-induced Nausea and Vomitting Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chemotheraphy-induced Nausea and Vomitting Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chemotheraphy-induced Nausea and Vomitting Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Chemotheraphy-induced Nausea and Vomitting Treatment Market Report

Report Metric Details
Report Name Chemotheraphy-induced Nausea and Vomitting Treatment Market
Accounted market size in year US$ 2284 million
Forecasted market size in 2031 US$ 1993 million
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck & Co, Tesaro, Acacia Pharma, Aphios, Barr Laboratories, Baxter Healthcare, Eisai, Especificos Stendhal, F.Hoffmann La Roche, Mundipharma, Mylan Pharmaceuticals, OPKO Health, Orchid Healthcare
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Chemotheraphy-induced Nausea and Vomitting Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

What is the Chemotheraphy-induced Nausea and Vomitting Treatment Market size in 2031?

Ans: The Chemotheraphy-induced Nausea and Vomitting Treatment Market size in 2031 will be US$ 1993 million.

Who are the main players in the Chemotheraphy-induced Nausea and Vomitting Treatment Market report?

Ans: The main players in the Chemotheraphy-induced Nausea and Vomitting Treatment Market are GlaxoSmithKline, Helsinn, Heron Therapeutics, Merck & Co, Tesaro, Acacia Pharma, Aphios, Barr Laboratories, Baxter Healthcare, Eisai, Especificos Stendhal, F.Hoffmann La Roche, Mundipharma, Mylan Pharmaceuticals, OPKO Health, Orchid Healthcare

What are the Application segmentation covered in the Chemotheraphy-induced Nausea and Vomitting Treatment Market report?

Ans: The Applications covered in the Chemotheraphy-induced Nausea and Vomitting Treatment Market report are Acute Nausea and Vomitting Treatment, Delayed Nausea and Vomitting Treatment, Anticipatory Nausea and Vomitting Treatment

What are the Type segmentation covered in the Chemotheraphy-induced Nausea and Vomitting Treatment Market report?

Ans: The Types covered in the Chemotheraphy-induced Nausea and Vomitting Treatment Market report are 5-HT3 Inhibitors, NK1 Inhibitors, Others

Recommended Reports

Cancer Therapy Solutions

Supportive Care Markets

Advanced Therapy Technologies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 5-HT3 Inhibitors
1.2.3 NK1 Inhibitors
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Nausea and Vomitting Treatment
1.3.3 Delayed Nausea and Vomitting Treatment
1.3.4 Anticipatory Nausea and Vomitting Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Perspective (2020-2031)
2.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Growth Trends by Region
2.2.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Region (2020-2025)
2.2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2026-2031)
2.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Dynamics
2.3.1 Chemotheraphy-induced Nausea and Vomitting Treatment Industry Trends
2.3.2 Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
2.3.3 Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
2.3.4 Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue
3.1.1 Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Revenue (2020-2025)
3.1.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue
3.4 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio
3.4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2024
3.5 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment Head office and Area Served
3.6 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Product and Application
3.7 Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Type
4.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Type (2020-2025)
4.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2026-2031)
5 Chemotheraphy-induced Nausea and Vomitting Treatment Breakdown Data by Application
5.1 Global Chemotheraphy-induced Nausea and Vomitting Treatment Historic Market Size by Application (2020-2025)
5.2 Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2020-2031)
6.2 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025)
6.4 North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2020-2031)
7.2 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025)
7.4 Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2020-2031)
8.2 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2020-2031)
9.2 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025)
9.4 Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (2020-2031)
10.2 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Helsinn
11.2.1 Helsinn Company Details
11.2.2 Helsinn Business Overview
11.2.3 Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.2.4 Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.2.5 Helsinn Recent Development
11.3 Heron Therapeutics
11.3.1 Heron Therapeutics Company Details
11.3.2 Heron Therapeutics Business Overview
11.3.3 Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.3.4 Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.3.5 Heron Therapeutics Recent Development
11.4 Merck & Co
11.4.1 Merck & Co Company Details
11.4.2 Merck & Co Business Overview
11.4.3 Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.4.4 Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.4.5 Merck & Co Recent Development
11.5 Tesaro
11.5.1 Tesaro Company Details
11.5.2 Tesaro Business Overview
11.5.3 Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.5.4 Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.5.5 Tesaro Recent Development
11.6 Acacia Pharma
11.6.1 Acacia Pharma Company Details
11.6.2 Acacia Pharma Business Overview
11.6.3 Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.6.4 Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.6.5 Acacia Pharma Recent Development
11.7 Aphios
11.7.1 Aphios Company Details
11.7.2 Aphios Business Overview
11.7.3 Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.7.4 Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.7.5 Aphios Recent Development
11.8 Barr Laboratories
11.8.1 Barr Laboratories Company Details
11.8.2 Barr Laboratories Business Overview
11.8.3 Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.8.4 Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.8.5 Barr Laboratories Recent Development
11.9 Baxter Healthcare
11.9.1 Baxter Healthcare Company Details
11.9.2 Baxter Healthcare Business Overview
11.9.3 Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.9.4 Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.9.5 Baxter Healthcare Recent Development
11.10 Eisai
11.10.1 Eisai Company Details
11.10.2 Eisai Business Overview
11.10.3 Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.10.4 Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.10.5 Eisai Recent Development
11.11 Especificos Stendhal
11.11.1 Especificos Stendhal Company Details
11.11.2 Especificos Stendhal Business Overview
11.11.3 Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.11.4 Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.11.5 Especificos Stendhal Recent Development
11.12 F.Hoffmann La Roche
11.12.1 F.Hoffmann La Roche Company Details
11.12.2 F.Hoffmann La Roche Business Overview
11.12.3 F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.12.4 F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.12.5 F.Hoffmann La Roche Recent Development
11.13 Mundipharma
11.13.1 Mundipharma Company Details
11.13.2 Mundipharma Business Overview
11.13.3 Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.13.4 Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.13.5 Mundipharma Recent Development
11.14 Mylan Pharmaceuticals
11.14.1 Mylan Pharmaceuticals Company Details
11.14.2 Mylan Pharmaceuticals Business Overview
11.14.3 Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.14.4 Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.14.5 Mylan Pharmaceuticals Recent Development
11.15 OPKO Health
11.15.1 OPKO Health Company Details
11.15.2 OPKO Health Business Overview
11.15.3 OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.15.4 OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.15.5 OPKO Health Recent Development
11.16 Orchid Healthcare
11.16.1 Orchid Healthcare Company Details
11.16.2 Orchid Healthcare Business Overview
11.16.3 Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Introduction
11.16.4 Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
11.16.5 Orchid Healthcare Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Helsinn
Heron Therapeutics
Merck
Tesaro
Acacia Pharma
Aphios
Barr Laboratories
Baxter Healthcare
Eisai Co Ltd
Especificos Stendhal
F.Hoffmann-La Roche
Mundipharma
Mylan Pharmaceuticals
OPKO Health
Orchid Healthcare
List of Tables
 Table 1. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of 5-HT3 Inhibitors
 Table 3. Key Players of NK1 Inhibitors
 Table 4. Key Players of Others
 Table 5. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2020-2025)
 Table 9. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2026-2031)
 Table 11. Chemotheraphy-induced Nausea and Vomitting Treatment Market Trends
 Table 12. Chemotheraphy-induced Nausea and Vomitting Treatment Market Drivers
 Table 13. Chemotheraphy-induced Nausea and Vomitting Treatment Market Challenges
 Table 14. Chemotheraphy-induced Nausea and Vomitting Treatment Market Restraints
 Table 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2024)
 Table 18. Ranking of Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Product and Application
 Table 22. Global Key Players of Chemotheraphy-induced Nausea and Vomitting Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Chemotheraphy-induced Nausea and Vomitting Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Chemotheraphy-induced Nausea and Vomitting Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. GlaxoSmithKline Company Details
 Table 48. GlaxoSmithKline Business Overview
 Table 49. GlaxoSmithKline Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 50. GlaxoSmithKline Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 51. GlaxoSmithKline Recent Development
 Table 52. Helsinn Company Details
 Table 53. Helsinn Business Overview
 Table 54. Helsinn Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 55. Helsinn Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 56. Helsinn Recent Development
 Table 57. Heron Therapeutics Company Details
 Table 58. Heron Therapeutics Business Overview
 Table 59. Heron Therapeutics Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 60. Heron Therapeutics Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 61. Heron Therapeutics Recent Development
 Table 62. Merck & Co Company Details
 Table 63. Merck & Co Business Overview
 Table 64. Merck & Co Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 65. Merck & Co Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 66. Merck & Co Recent Development
 Table 67. Tesaro Company Details
 Table 68. Tesaro Business Overview
 Table 69. Tesaro Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 70. Tesaro Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 71. Tesaro Recent Development
 Table 72. Acacia Pharma Company Details
 Table 73. Acacia Pharma Business Overview
 Table 74. Acacia Pharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 75. Acacia Pharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 76. Acacia Pharma Recent Development
 Table 77. Aphios Company Details
 Table 78. Aphios Business Overview
 Table 79. Aphios Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 80. Aphios Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 81. Aphios Recent Development
 Table 82. Barr Laboratories Company Details
 Table 83. Barr Laboratories Business Overview
 Table 84. Barr Laboratories Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 85. Barr Laboratories Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 86. Barr Laboratories Recent Development
 Table 87. Baxter Healthcare Company Details
 Table 88. Baxter Healthcare Business Overview
 Table 89. Baxter Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 90. Baxter Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 91. Baxter Healthcare Recent Development
 Table 92. Eisai Company Details
 Table 93. Eisai Business Overview
 Table 94. Eisai Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 95. Eisai Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 96. Eisai Recent Development
 Table 97. Especificos Stendhal Company Details
 Table 98. Especificos Stendhal Business Overview
 Table 99. Especificos Stendhal Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 100. Especificos Stendhal Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 101. Especificos Stendhal Recent Development
 Table 102. F.Hoffmann La Roche Company Details
 Table 103. F.Hoffmann La Roche Business Overview
 Table 104. F.Hoffmann La Roche Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 105. F.Hoffmann La Roche Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 106. F.Hoffmann La Roche Recent Development
 Table 107. Mundipharma Company Details
 Table 108. Mundipharma Business Overview
 Table 109. Mundipharma Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 110. Mundipharma Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 111. Mundipharma Recent Development
 Table 112. Mylan Pharmaceuticals Company Details
 Table 113. Mylan Pharmaceuticals Business Overview
 Table 114. Mylan Pharmaceuticals Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 115. Mylan Pharmaceuticals Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 116. Mylan Pharmaceuticals Recent Development
 Table 117. OPKO Health Company Details
 Table 118. OPKO Health Business Overview
 Table 119. OPKO Health Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 120. OPKO Health Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 121. OPKO Health Recent Development
 Table 122. Orchid Healthcare Company Details
 Table 123. Orchid Healthcare Business Overview
 Table 124. Orchid Healthcare Chemotheraphy-induced Nausea and Vomitting Treatment Product
 Table 125. Orchid Healthcare Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025) & (US$ Million)
 Table 126. Orchid Healthcare Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Chemotheraphy-induced Nausea and Vomitting Treatment Picture
 Figure 2. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Type: 2024 VS 2031
 Figure 4. 5-HT3 Inhibitors Features
 Figure 5. NK1 Inhibitors Features
 Figure 6. Others Features
 Figure 7. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Acute Nausea and Vomitting Treatment Case Studies
 Figure 10. Delayed Nausea and Vomitting Treatment Case Studies
 Figure 11. Anticipatory Nausea and Vomitting Treatment Case Studies
 Figure 12. Chemotheraphy-induced Nausea and Vomitting Treatment Report Years Considered
 Figure 13. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Players in 2024
 Figure 17. Global Top Chemotheraphy-induced Nausea and Vomitting Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotheraphy-induced Nausea and Vomitting Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Chemotheraphy-induced Nausea and Vomitting Treatment Revenue in 2024
 Figure 19. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2020-2031)
 Figure 21. United States Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Region (2020-2031)
 Figure 33. China Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Chemotheraphy-induced Nausea and Vomitting Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Chemotheraphy-induced Nausea and Vomitting Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. GlaxoSmithKline Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 49. Helsinn Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 50. Heron Therapeutics Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 51. Merck & Co Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 52. Tesaro Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 53. Acacia Pharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 54. Aphios Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 55. Barr Laboratories Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 56. Baxter Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 57. Eisai Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 58. Especificos Stendhal Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 59. F.Hoffmann La Roche Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 60. Mundipharma Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 61. Mylan Pharmaceuticals Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 62. OPKO Health Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 63. Orchid Healthcare Revenue Growth Rate in Chemotheraphy-induced Nausea and Vomitting Treatment Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano String

SIMILAR REPORTS

Global Treatment Planning Software Market Research Report 2025
Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drug Delivery Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chemical Dosing Units Market Research Report 2025
Global Combination Therapy Drug Market Research Report 2025
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Drug Safety and Pharmacovigilance Service Market Research Report 2025
OTC Anti nausea Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Diagnostic Guidewire Market Research Report 2024
Ophthalmology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antidepressants Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Critical Care Therapeutics Market Research Report 2025
Global Drugs of Abuse Testing Market Research Report 2024
Radiation Therapy Treatment Planning System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cancer Therapeutics and Biotherapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions